Our Team
Synergy
Our international team leaders work seamlessly together
in developing world-class medical technology products.
Michael Burnam, MD
CEO, Founder, Director
Award-winning scientist, inventor, and clinician with thirty years of biotech executive experience. Co-invented one of the first heart attack blood tests, was nominated for the Yallow-Berson International Prize in Immunology, and invented and achieved FDA clearance for a pre-calibrated and disposable potassium blood test.
Srikanth Jadcherla, MS
CTO, Founder, Director
Engineer, Educator and Entrepreneur and one of the world’s leading experts on mobile electronics’ design and verification. Chairman of Global Technology University and Founder/CEO of iMedrix Inc in addition to helping med-tech startups architect lasting solutions. Recipient of the Intel Achievement Award and has 10 patents.
Michael Coyle, MBA
Director
Coyle served as Executive Vice President and President for the Cardiovascular Portfolio at Medtronic, a position he held until November 2020. He was responsible for optimizing Medtronic enterprise performance by supporting capital allocation, talent management, investments, and collaboration to create value across all of Medtronic’s Operating Units. Prior to Medtronic, he provided leadership Read More
Robert Develle, PA
Consultant
Involved with BaroPace’s Clinical Affairs. Directed clinical study operations for St Jude Medical/Abbott for several large human studies including most recently a pivotal randomized FDA trial of 236 enrolled subjects.
David Blinbaum
Business Advisor
David began his career at Bear Stearns within the Global Industries Group with expertise in M&A and both debt and equity financings. He currently holds a senior investment role at a multi-billion-dollar asset management firm. His proficiencies encompass structured finance, liability management solutions, debt and equity capital raising, corporate advisory, and strategic capital investment.
Mark W. Kroll, PhD, FACC, FHRS, FIEEE, FAIMBE
Member, Scientific Advisory Board
Biomedical scientist specializing in Bioelectricity and Biomechanics. Former Senior VP and Chief Technology Officer of St Jude Medical. Author of hundreds of peer-reviewed scientific papers and over 380 issued US patents, the vast majority for implantable medical devices. Adjunct full professor of Biomedical Engineering at California Polytechnic University.
Elisabeth Neely, BA, BS
Member, Scientific Advisory Board
Former VP and Global Director of Regulatory Affairs for St Jude Medical, Senior VP for Clinical and Regulatory Affairs for Procyrion, Inc. Regulatory consultant to biomedical companies.
Florian Rader, MD, MSc
Member, Scientific Advisory Board
A clinical investigator, specializing in the management of hypertension and hypertrophic cardiomyopathy. He serves as Medical Director of the Hypertension Center of Excellence and Co-Director of the Hypertrophic Cardiomyopathy Center at Read More
Michael Burnam, MD
CEO, Founder, Director
Award-winning scientist, inventor, and clinician with thirty years of biotech executive experience. Co-invented one of the first heart attack blood tests, was nominated for the Yallow-Berson International Prize in Immunology, and invented and achieved FDA clearance for a pre-calibrated and disposable potassium blood test.
Srikanth Jadcherla, MS
CTO, Founder, Director
Engineer, Educator and Entrepreneur and one of the world’s leading experts on mobile electronics’ design and verification. Chairman of Global Technology University and Founder/CEO of iMedrix Inc in addition to helping med-tech startups architect lasting solutions. Recipient of the Intel Achievement Award and has 10 patents.
Michael Coyle, MBA
Director
Coyle served as Executive Vice President and President for the Cardiovascular Portfolio at Medtronic, a position he held until November 2020. He was responsible for optimizing Medtronic enterprise performance by supporting capital allocation, Read More
Robert Develle, PA
Consultant
Involved with BaroPace’s Clinical Affairs. Directed clinical study operations for St Jude Medical/Abbott for several large human studies including most recently a pivotal randomized FDA trial of 236 enrolled subjects.
David Blinbaum
Business Advisor
David began his career at Bear Stearns within the Global Industries Group with expertise in M&A and both debt and equity financings. He currently holds a senior investment role at a multi-billion-dollar asset management firm. His proficiencies encompass structured finance, liability management solutions, debt and equity capital raising, corporate advisory, and strategic capital investment.
Mark W. Kroll, PhD, FACC, FHRS, FIEEE, FAIMBE
Member, Scientific Advisory Board
Biomedical scientist specializing in Bioelectricity and Biomechanics. Former Senior VP and Chief Technology Officer of Read More
Elisabeth Neely, BA, BS
Member, Scientific Advisory Board
Former VP and Global Director of Regulatory Affairs for St Jude Medical, Senior VP for Clinical and Regulatory Affairs for Procyrion, Inc. Regulatory consultant to biomedical companies.
Florian Rader, MD, MSc
Member, Scientific Advisory Board
A clinical investigator, specializing in the management of hypertension and hypertrophic cardiomyopathy. He serves as Medical Director of the Hypertension Center of Excellence and Co-Director of the Hypertrophic Cardiomyopathy Center at Read More